心脏性冲击管理和研究:过去,现在和未来的前景
Sascha Ott1,2,3, Laura Leser1, Pia Lanmüller2,4
1Department of Cardiac Anesthesiology and Intensive Care Medicine, German Heart Center Berlin Berlin, Germany.
尽管取得了进展,但心脏性休克 (CS) 管理仍然具有挑战性. 本综述涵盖了CS病史,治疗方法和改善急性心力衰竭患者治疗结果的未来方向.
科学领域:
- 心脏病学 心脏病学
- 关键护理医学 关键护理医学
背景情况:
- 心脏性休克 (CS) 的发病率和死亡率仍然很高.
- 急性心肌梗塞 (MI) 是最常见的CS原因,但其他急性心力衰竭表型也存在.
研究的目的:
- 审查心脏性休克的病史,里程碑性试验和当前的治疗策略.
- 讨论医疗疗法,机械循环支持和CS管理的未来前景.
主要方法:
- 关于心脏性休克管理的文献综述.
- 讨论历史背景,临床试验和治疗选择.
主要成果:
- 尽管取得了进展,但许多当前CS治疗方案的证据是有限的.
- 实施大规模的CS随机对照试验具有挑战性.
结论:
- 优化心脏性休克管理需要进一步的研究和强大的临床试验.
- 未来的展望集中在推进医学治疗和机械循环支持,以改善患者的生存率.
更多相关视频
07:39Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock
Published on: August 16, 2021
14:35Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs
Published on: April 17, 2021
相关概念视频
Blood Pressure Imbalances and Circulatory Shock
Blood Pressure: Hypertension and Hypotension
Normal blood pressure is 120/80 mm Hg. Elevated blood pressure is 120-129/under 80 mm Hg. Hypertension, warranting treatment at 130/80 mm Hg, is often asymptomatic and can lead to severe cardiovascular events, aneurysms, peripheral arterial disease, chronic renal disease, or cardiac...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Myocarditis III: Medical Management
Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
Pericarditis IV: Nursing Management
Aortic Regurgitation IV: Nursing Management
